REG - Hikma Pharmaceutical - Director/PDMR Shareholding <Origin Href="QuoteRef">HIK.L</Origin>

Hikma PharmaceuticalsAnnouncement

28/04/2017 14:00

RNS Number : 7250D
Hikma Pharmaceuticals Plc
28 April 2017
Notification and public disclosure of transactions by persons discharging managerial responsibilities
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Michael Raya
2
Reason for the notification
a)
Position/status
CEO of West-Ward Pharmaceuticals
b)
Initial notification /Amendment
Amendment
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083
b)
Nature of the transaction
Purchase of 10,272 shares in the Company in compliance with the Company's shareholding requirement.
c)
Price(s) and volume(s)
Price(s): 18.689
Volume(s): 10,272
d)
Aggregated information
Price(s): 18.689

Volume(s): 10,272
Total: 191,973.41
e)
Date of the transaction
26 April 2017
f)
Place of the transaction
London Stock Exchange (XLON)

This information is provided by RNS
The company news service from the London Stock Exchange
  END
DSHBDGDSUUDBGRI